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ABSTRACT 
Objective: The present study aims to prepare a mouth dissolving film of ramosetron hydrochloride to provide relief to cancer patients suffering 
from nausea and vomiting. 
Methods: Mouth dissolving film of ramosetron hydrochloride were prepared and optimized using three levels two factor design. The films were 
prepared using the solvent casting technique. The effect of formulation variables such as the concentration of HPMC E15, and honey on 
disintegration time, tensile strength and drug release from the film were studied. The films were evaluated for weight, thickness, folding endurance, 
tensile strength, percent elongation, surface pH, disintegration time and drug release. 
Results: All the films were found to be transparent, non-sticky and easily peelable. The concentration of HPMC E 15 and Honey was found to have a 
significant effect on disintegration time and drug release of the mouth dissolving film. Formulation R1 was found to the best formulation with 
104.21 % release in 9 min and disintegration time of 57 seconds. 
Conclusion: It can be concluded that the developed mouth dissolving film could serve as an effective, convenient alternative to prevent nausea and 
vomiting in cancer patients of any age group. 
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Nausea and vomiting are very common symptoms in cancer patients 
on chemo or radiation therapy [1, 2]. About 70-80% patient on 
treatment suffer from nausea and vomiting of varying severity [3]. 
This deteriorates the quality of life of cancer patients [1]. There are 
various national and international guidelines developed to prevent 
nausea and vomiting in cancer patients [4]. Advent of 5HT3 
Antagonist has significantly improved control over nausea and 
vomiting in cancer patients [5].  
Ramosetron hydrochloride is a tetrahydro benzimidazole derivative. 
It is a potent and selective 5HT3 receptor antagonist. It has the high 
binding affinity and dissociates slowly from the target receptors due 
to which it has long-lasting effects than the older agents [5]. 
Ramosetron hydrochloride is administered as 0.1 mg oral tablet for 
prevention of nausea and vomiting in cancer patients. Cancer is a 
disease that can occur in any age group from children, adults to 
geriatric patients. Conventional dosage forms like tablets and 
capsules have to be swallowed with the help of water and hence is a 
disadvantage for patients who have difficulty in swallowing. Mouth 
dissolving films is an advanced oral dosage form that disintegrates 
and dissolves in the mouth without uptake of water and eliminates 
the need of swallowing the dosage form. It caters to patients who 
have difficulty in swallowing, unlike conventional dosage forms. The 
present research work aims in preparing a mouth dissolving film of 
ramosetron hydrochloride that would prevent nausea and vomiting 
and offer ease of administration to cancer patients of any age group 
and also to cancer patients suffering from dysphagia. 
MATERIALS AND METHODS 
Ramosetron Hydrochloride was obtained as a gift sample from 
Cadila Healthcare Ltd, Kundaim Goa. HPMC E15 was provided as a 
gift sample from Colorcon Asia pvt Ltd, Verna Goa. Dabur Honey was 
purchased from the local market. Sodium alginate, carageenan were 
provided as gift sample by Snap Alginate Ltd Mumbai. Ethanol and 
propylene glycol was purchased from S. D fine chemicals limited. 
Citric acid and methylparaben were procured from Molychem 
Mumbai. Ascorbic acid was purchased from Avra synthesis Pvt Ltd, 
Aspartame was purchased from Ozone Chemicals Mumbai. PEG 400 
was purchased from Hi-Media Pvt ltd. Distilled water prepared using 
in house plant was used for the research work. 
Preliminary trials 
Various film-forming polymers such as hydroxypropyl 
methylcellulose (HPMC) E15, sodium alginate, carageenan were 
screened for film forming capacity of which HPMC E15 was found be 
the best polymer forming the transparent and stiff film, and hence 
was selected. Honey was screened for its film modifying property 
when used in combination with HPMC E15. The drug ramosetron 
hydrochloride has good solubility in cosolvent ethanol and hence 
was used and studied for its effects on film formation. 
Experimental design/preparation of mouth dissolving films 
An experimental design consisting of nine formulations was set up, 
using two factors at three levels to statistically optimize mouth 
dissolving film of ramosetron hydrochloride. Solvent casting 
technique was used in the preparation of films. The independent 
variables used included two numeric factors X1-Concentration of 
HPMC E15, X2–Concentration of honey. The responses used for 
statistical optimization included Y1-Disintegration Time in seconds, 
Y2–Tensile strength of films in Kg/cm2and Y3-Drug Release at 9 
min. The composition of the films prepared is given in table 1.  
HPMC E15, used as the film-forming agent was soaked in the 
ethanol-water mixture overnight. The polymer solution was stirred 
on a magnetic stirrer until homogenous. Honey used as film modifier 
was added to the polymer solution followed by PEG 400 used as the 
plasticizer and stirred till homogenous. Citric acid, used as saliva 
stimulating agent, ascorbic acid as antioxidant and flavoring agent 
aspartame as sweetening agent and drug was dissolved in the 
remaining amount of water and added to the polymer solution. This 
was followed by addition of methylparaben used as the preservative, 
which was previously dissolved in propylene glycol. The prepared 
formulation was casted on glass petriplate and dried at room 
temperature. The dried films were carefully peeled and cut in 2 cm x 
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2 cm films wrapped in aluminum foil and stored in desiccators. The 
prepared films were evaluated for weight, thickness, surface pH, 
folding endurance, disintegration time, tensile strength, percent 
elongation, drug release, assay, and stability. 
 
Table 1: Composition of ramosetron hydrochloride mouth dissolving formulation 
Ingredients R1 R2 R3 R4 R5 R6 R7 R8 R9 
Ramosetron HCL (mg) 1.58 1.58 1.58 1.58 1.58 1.58 1.58 1.58 1.58 
HPMC E15 (%) 3.5 3.75 4 3.5 3.75 4 3.5 3.75 4 
Honey (%) 2 2 2 3 3 3 4 4 4 
PEG 400 (%) 1 1 1 1 1 1 1 1 1 
Methyl Paraben (%) 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
Citric acid(%) 1 1 1 1 1 1 1 1 1 
Ascorbic acid (%) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
Aspartame(%) 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
Propylene glycol(%) 1 1 1 1 1 1 1 1 1 
Ethanol (ml) 5 5 5 5 5 5 5 5 5 
Water qs (ml) 10  10 10 10 10 10 10 10 10 
  
Drug-excipient compatibility 
The formulation in the dry state was tested for drug excipient 
compatibility. The study was carried out using differential scanning 
calorimetry (Universal V4SA TA). The thermograms of drug alone 
and drug with polymer were recorded at a scanning rate of 1℃ per 
minute in temperature range of-100 ℃ to 400 ℃ in a nitrogen 
atmosphere. The recorded thermograms were checked for any 
unusual change in appearance or shift in the peaks. 
Evaluation of mouth dissolving film 
Physical appearance  
The films obtained were checked visually for uniformity, clarity and 
tackiness. 
Microscopy 
The morphology and topography of the prepared films was observed 
by placing a 2 cm x 2 cm cut film under the scanning electron 
microscope 
Weight 
The prepared and cut films of 2 cm x 2 cm were weighed on 
sartorius electronic balance. An average and standard deviation of 
the reading of three films were recorded. 
Thickness 
The thickness of the film was measured at three places per film 
using micrometer (Mitutoyo, Japan). Average of the readings of three 
films were recorded. 
Folding endurance 
The films were individually folded in a plane manually till it 
produced visible crack and number of times it was folded to produce 
visible crack was noted as the folding endurance. An average of 
three films was recorded [6, 7]. 
Tensile strength 
Tensile strength is the maximum stress applied on the film till it 




film thickness × film width × 100 
An average and standard deviation of three readings of films were 
recorded. 
Disintegration time 
Disintegration test apparatus IP was used to measure the 
disintegration time of the films. Average of the readings of three 
films were recorded and standard deviation found. 
Drug release  
The drug release was determined using a modified dissolution apparatus 
as used by Dinge et al. 20 ml of phosphate buffer pH 6.8 was used as 
dissolution medium. The films were placed in 50 ml beaker containing 
20 ml of dissolution medium and suspended in Dissolution apparatus-IP 
and run at speed of 50 rpm. The sample was drawn at 3, 6, 9,12,15,18, 21 
min and content was measured spectrophotometrically at 248 nm using 
UV1800 (Shimadzu, Japan) [9]. 
Statistical optimization using the design of experiments 
Design expert trial version 11.0 software of Stat ease Inc was used 
for optimization of ramosetron hydrochloride mouth dissolving 
films. Two way ANOVA at the significance level of *P<0.05 and 
response surface graphs were used to find the contribution of each 
independent variable on the response. 
Stability study 
The best formulation was tested for stability at room temperature 
and ambient humidity for 90 d [6]. 
RESULTS AND DISCUSSION 
Preliminary trials 
The drug ramosetron hydrochloride is water soluble hence film-
forming polymers that would form transparent films would be ideal. 
Hence placebo films were prepared using polymers, such as HPMC 
E15, sodium alginate and carrageenan. HPMC E15 was found to 
produce good results with non-tacky, transparent film. Among the 
plasticizers’ used PEG 400, Propylene glycol and honey were 
screened. Honey, when used alone, produced stiff and crisp films 
that were difficult to peel while PEG 400 and propylene glycol 
produced easily peelable films but they lacked stiffness. Hence 
honey in combination with PEG 400 was used wherein honey would 
provide the necessary stiffness while PEG 400 would allow ease of 
removal of the film. Since the formulation incorporated honey, 
methylparaben was used as the preservative in the formulation. 
Experimental design 
The preliminary trials for the formulation of mouth dissolving film 
helped to select the factors for the study and the concentration to be 
used. The layout of the factorial design and the responses is as given 
in table 2. 
Drug-excipient compatibility 
On comparison of the thermogram of pure drug Ramosetron 
Hydrochloride fig. 1 and drug with excipients fig. 2, it was observed 
that the endothermic peak of the pure drug was found to be at 
228.66 ℃ while in presence of excipients it was found to be at 
231.65 ℃. The slight shift may be due to the presence of polymers. 
Since there were no major changes in thermogram it ruled out any 
possibility of incompatibility. 
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Table 2: Layout of factorial design 
Code Coded values Actual values in percentage (%)  Dependent variables  
X1 X2 X1 X2 Y1 Y2 Y3 
R1 -1 -1 3.5 2 59.00 75.65 107.32 
R2  0 -1 3.75 2 66.66 82.47 104.49 
R3 +1 -1 4 2 73.00 91.09 90.34 
R4 -1  0 3.5 3 70.00 85.68 89.07 
R5  0  0 3.75 3 77.00 94.33 79.02 
R6 +1  0 4 3 89.00 100.84 74.89 
R7 -1 +1 3.5 4 90.00 95.68 84.73 
R8  0 +1 3.75 4 94.66 104.67 79.77 
R9 +1 +1 4 4 110.98 113.07 62.52 




Fig. 1: DSC spectra of ramosetron hydrochloride 
 
 
Fig. 2: DSC Spectra of ramosetron hydrochloride and excipients 
 
Evaluation of films 
All the prepared films were found to have good clarity, uniformity, 
were easily peelable and nonsticky. The scanning electron 
microscopy of the film (fig. 3) revealed that the films were smooth 
and clear with the uniform distribution of the drug. The films were 
found to weigh between 43.33 mg and 80.00 mg having thickness 
between 0.096 mm and 0.136 mm. The folding endurance was found 
to be in the range of 745.33 to 946.33. Increase in concentration of 
HPMC E15 and honey increased the folding endurance of the mouth 
dissolving films. The pH of all the films was found to be between 
6.66-6.79 which is close to neutral pH and rules out any chances of 
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irritation of oral mucosa. The percent elongation of all the films was 
found to be between 1.66 % and 9.83 %. The assay values of all the 
films were found to be in the range of 98.05 % and 102.17 %. The 
drug release profile of the films is as shown in fig. 4. 
 
 
Fig. 3: SEM of ramosetron hydrochloride mouth dissolving the film 
 
Table 3: Physicochemical characterization of the mouth dissolving film 
Code Weight (mg) Thickness (mm)a Folding endurancea a pH  % Elongationa Assay (%)a a 
R1 43.33±2.08 0.096±0.005 745.33±3.51 6.66±0.01 1.66±0.72 100.83±1.08 
R2 54.0±3.60 0.10±0.01 753.33±3.05 6.70±0.01 2.91±0.72 100.62±0.85 
R3 75.0±2.64 0.113±0.005 806.33±3.05 6.70±0.01 3.33±0.72 102.17±1.22 
R4 58.33±4.08 0.113±0.005 814.0±3.60 6.75±0.01 4.16±0.72 100.15±1.31 
R5 63.33±2.08 0.110±0.01 822.66±2.51 6.78±0.01 6.25±0.0 100.75±1.07 
R6 73.0±1.0 0.123±0.0005 839±3.60 6.76±0.01 7.75±0.43 101.75±1.84 
R7 71.0±3.60 0.133±0.005 867±3.00 6.77±0.01 6.0±0.90 98.05±1.68 
R8 72.33±2.51 0.126±0.005 879±3.60 6.79±0.01 8.0±0.43 101.58±0.45 





Fig. 4: Percent drug release profile of all mouth dissolving film formulation (mean±SD n=3) 
 
Statistical analysis 
The design expert software 11.0 trial version helps to determine the 
model that best suits for the correlation between dependent 
variables and independent variables. The best-suited model was 
selected on the basis of parameters of regression analysis namely p 
value, adjusted and predicted R2
The 3
value [10]. ANOVA is implemented 
at 5% level of significance.  
Effect of formulation variables on disintegration time 
2factorial design on screening the data depicted a linear model 
as a best fit for response Y1 i. e disintegration time having p 
value<0.0001, adjusted R2 of 0.9574 and predicted R2
X1 and X2 were found to be significant factors having agonistic effect 
on the disintegration time and the same has been demonstrated in 
the response surface plot fig. 5, which shows an increase in the 
concentration of HPMC E15 and honey, increases the disintegration 
time of the film. X2 has a greater influence on disintegration time as 
seen from the coefficient value (16.16) than X1 (9.0). of 0.9224 
(table 4). The adequate precision which measures signal to noise 
ratio was found to be 25.950. A ratio greater than 4 is desired.  
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Fig. 5: Response surface plot for disintegration time 
 
Effect of formulation variables on tensile strength 
The analysis of response 2 shows a linear model as a best-fit model 
(table 4). The p-value was found to be<0.0001 hence the model was 
found to be significant, while the adjusted R2 of 0.9574 and 
predicted R2
Tensile strength in kg/cm
of 0.9224 were found to be in reasonable agreement 
with each other that is the difference was less than 0.2. The adequate 
precision was found to be 93.419. The polynomial equation 
generated by the software for response Y2 is as given below:  
2
From the equation, it can be predicted that X2 has the greater 
influence on tensile strength as seen from the beta coefficient value 
of 10.70 than the value of 8.0 coefficient value for X1. The response 
surface plot revealing the influence of independent variables, honey 
and HPMC E15 is depicted in fig. 6. Increase in concentration of 
honey made the film more robust and stiff than the use of just mere 
HPMC E15 polymer. 
 =+93.72+8.00X1+10.70X2 ------------- (2) 
 
 
Fig 6: Response surface plot for tensile strength 
 
Effect of formulation variables on drug release 
Response 3 (Y3) analysis also shows the linear model as a best-fit 
model (table 4) with a p-value of 0.00013, the adjusted R2 of 0.8550 
and predicted R2
Drug release at 9 min (Y3) =+85.79-8.90X1-12.52 X2 ----------- (3) 
of 0.8013. The adequate precision was found to be 
13.828. The polynomial equation for Y3 is as given below:  
From the equation, it can be interpreted that formulation 
variables X1 and X2 have an antagonistic influence on the drug 
release at 9 min from the mouth dissolving films as the 
coefficient estimate of X1 and X2 have negative values of-8.90 
and-12.52 respectively. The increase in the concentration of 
HPMCE15 and Honey decreases the release of the drug from the 
mouth dissolving as depicted in fig. 7. 
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Fig. 7: Response surface plot for drug release 
 
Table 4: Fit summary of the highest order polynomial of responses 
Response/ Y1 Y2 Y3 
Source f value p Value f value p value f value p Value 
Linear vs Mean 91.00 <0.0001 1113.70 <0.0001 24.59 0.0013 
2FI vs Linear 1.10 0.3428 2.46 0.1778 0.2061 0.6688 
Quadratic vs 2FI 4.12 0.1377 0.0784 0.9264 4.06 0.1402 
 
Statistical optimization 
Optimization of the ramosetron hydrochloride mouth dissolving film 
was done using the design expert software 11.0 trial version by 
setting the desired goals for the responses. The goals set for the 
present study was to have minimum disintegration time and 
maximum drug release at 9 min. The software provided four 
solutions based on the goals. One of the solutions provided by the 
software was among the formulation batches ie R1. Formulation R1 
was chosen as the best-optimized formulation having desirability of 
0.9999 that would give a mouth dissolving film of ramosetron 
hydrochloride having predicted disintegration time of 55.98 
seconds, the tensile strength of 75.02 Kg/cm2 and that would release 
107.21 % drug at the end of 9 min. The optimized formulation 
showed the responses close to that predicted by the software. The 
actual responses of the optimized batch were found to have a 
disintegration time of 57.0 seconds, tensile strength of 75.02 Kg/cm2
Stability study 
 
and that would release 104.21 % drug at the end of 9 min.  
The stability studies done on the optimised batch were found to be 
within the specification. The films were clear, non-tacky having 
folding endurance of 730.00, disintegration time of 57 seconds and 
releasing 104.21% drug completely at the end of 9 min. 
CONCLUSION  
The mouth dissolving film of ramosetron hydrochloride that would 
provide ease of administration to cancer patients of any age group 
was successfully developed. Design of experiment was found to be a 
useful tool in understanding the influence of excipients on the 
performance of the film. The formulation batches were successfully 
optimized using design expert software. The formulation R1 was 
found to be the best-optimized batch with disintegration time of 57 
seconds and drug release of 104.21% drug at the end of 9 min. 
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